(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | (FY)Dec 31, 2018 | |
---|---|---|---|---|---|---|---|---|---|
Turnover | 31.07%165.06M | -40.62%359.37M | -51.52%125.94M | -25.57%605.21M | --259.77M | 10.79%813.18M | 9.58%734M | 6.03%669.85M | --631.76M |
Operating income | 31.07%165.06M | -40.62%359.37M | -51.52%125.94M | -25.57%605.21M | 259.77M | 10.79%813.18M | 9.58%734M | 6.03%669.85M | 631.76M |
Cost of sales | -68.10%-129.96M | 43.32%-266.95M | 60.00%-77.31M | 26.87%-470.99M | ---193.27M | -20.99%-644.01M | -7.43%-532.29M | 1.57%-495.47M | ---503.35M |
Operating expenses | -68.10%-129.96M | 43.32%-266.95M | 60.00%-77.31M | 26.87%-470.99M | -193.27M | -20.99%-644.01M | -7.43%-532.29M | 1.57%-495.47M | -503.35M |
Gross profit | -27.82%35.1M | -31.14%92.42M | -26.88%48.63M | -20.66%134.22M | 66.51M | -16.13%169.17M | 15.67%201.71M | 35.80%174.38M | 128.41M |
Selling expenses | 24.83%-27.65M | 16.21%-80.78M | 8.62%-36.78M | -31.95%-96.4M | ---40.25M | 1.49%-73.06M | -16.81%-74.16M | 7.79%-63.49M | ---68.86M |
Administrative expenses | -41.40%-22.27M | 27.79%-39.28M | 38.48%-15.75M | -23.63%-54.41M | ---25.6M | -101.27%-44.01M | -8.23%-21.87M | -8.29%-20.2M | ---18.66M |
Research and development expenses | -3.97%-26.49M | -13.47%-43.03M | -57.35%-25.48M | 13.56%-37.92M | ---16.19M | -45.21%-43.87M | 17.07%-30.21M | -56.85%-36.43M | ---23.23M |
Revaluation surplus | 45.75%-10.98M | -195.05%-19.12M | 57.64%-20.24M | -24.53%20.11M | ---47.79M | --26.65M | ---- | ---- | ---- |
-Changes in the fair value of financial assets | 45.75%-10.98M | ---- | 57.64%-20.24M | ---- | ---47.79M | --26.65M | ---- | ---- | ---- |
-Changes in the fair value of other assets | ---- | -195.05%-19.12M | ---- | --20.11M | ---- | ---- | ---- | ---- | ---- |
Impairment and provision | -55.23%-3.1M | -117.51%-3.65M | ---2M | ---1.68M | ---- | ---- | ---- | ---- | ---- |
-Other impairment is provision | -55.23%-3.1M | -117.51%-3.65M | ---2M | ---1.68M | ---- | ---- | ---- | ---- | ---- |
Special items of operating profit | -59.75%10.57M | -29.04%33.32M | 55.36%26.26M | 26.09%46.95M | --16.9M | 34.53%37.23M | 21.00%27.67M | 85.61%22.87M | --12.32M |
Operating profit | -76.71%-44.82M | -653.48%-60.12M | 45.37%-25.36M | -84.94%10.86M | -46.43M | -30.09%72.11M | 33.73%103.15M | 157.17%77.13M | 29.99M |
Financing cost | -303.45%-936K | -783.58%-1.18M | -141.67%-232K | -52.27%-134K | ---96K | 75.49%-88K | 70.74%-359K | 72.88%-1.23M | ---4.52M |
Earning before tax | -78.77%-45.76M | -671.42%-61.31M | 44.98%-25.6M | -85.10%10.73M | -46.52M | -29.93%72.03M | 35.41%102.79M | 198.03%75.91M | 25.47M |
Tax | 104.48%554K | -91.21%-11.23M | -398.89%-12.35M | -158.03%-5.87M | --4.13M | 193.92%10.12M | -66.51%-10.78M | -578.27%-6.47M | --1.35M |
After-tax profit from continuing operations | -19.12%-45.2M | -1,593.78%-72.54M | 10.47%-37.95M | -94.09%4.86M | -42.39M | -10.72%82.15M | 32.52%92.01M | 158.87%69.44M | 26.82M |
Earning after tax | -19.12%-45.2M | -1,593.78%-72.54M | 10.47%-37.95M | -94.09%4.86M | -42.39M | -10.72%82.15M | 32.52%92.01M | 158.87%69.44M | 26.82M |
Minority profit | 44.58%-133K | -209.07%-1.09M | -169.66%-240K | ---353K | ---89K | ---- | ---- | ---- | ---- |
Profit attributable to shareholders | -19.52%-45.07M | -1,471.61%-71.45M | 10.85%-37.71M | -93.66%5.21M | -42.3M | -10.72%82.15M | 32.52%92.01M | 158.87%69.44M | 26.82M |
Basic earnings per share | -25.46%-0.1355 | -1,357.83%-0.2088 | 28.24%-0.108 | -94.32%0.0166 | -0.1505 | -99.68%0.2922 | 28.57%90 | 70 | |
Diluted earnings per share | -25.46%-0.1355 | -4,361.22%-0.2088 | 28.24%-0.108 | -97.39%0.0049 | -0.1505 | -99.79%0.1877 | 28.57%90 | 70 | |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion |
Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | Ernst & Young | Ernst & Young | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data